Pharmaceutical Technology

JUNE 19, 2025

Can pharma tariffs “Make America Manufacture Again”? King said: “Manufacturing drugs in space sounds like sci-fi – but the time is now. Crystallisation is a process that is better in space compared to on Earth, and that’s because gravity inhibits that process.

Clinical Trials

Bio Pharma Dive

JUNE 23, 2025

Originally developed in the 1970s to treat diabetes, these drugs—such as Ozempic, Wegovy, and Mounjaro—have become headline-makers for their ability to induce significant weight loss. Understanding GLP-1 drugs GLP-1, or glucagon-like peptide-1 receptor modulators, mimic natural hormones that regulate insulin and appetite.

Gene Therapy

XTalks

JANUARY 29, 2025

Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drug delivery and drug-device combination product assembly in Rockford, Illinois.

Drug Delivery

Pharmaceutical Technology

JUNE 24, 2025

Can pharma tariffs “Make America Manufacture Again”? In the Research & Development category, i3 Membrane was honored for its efforts to scale DMC for commercial therapeutic drug manufacturing, demonstrating superior performance and efficiency.

Manufacturing

Pharmaceutical Technology

JULY 22, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? The latest manufacturing investment will support the ongoing development of Biogen’s late-stage clinical pipeline.

Research

Pharmaceutical Technology

JUNE 25, 2025

Can pharma tariffs “Make America Manufacture Again”? MGDs class drugs that act as molecular adhesives, enabling targeted degradation of a protein. Kymera’s drugs are designed to selectively eliminate cyclin-dependent kinase 2 (CDK2) proteins.

Drugs

Pharmaceutical Technology

JUNE 13, 2025

Can pharma tariffs “Make America Manufacture Again”? GSK previously received US Food and Drug Administration approval for Nucala (mepolizumab) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease that is inadequately controlled, and an eosinophilic phenotype.

Vaccination

Pharmaceutical Technology

JUNE 25, 2025

Can pharma tariffs “Make America Manufacture Again”? Biopharmaceutical companies developing Alzheimer’s disease innovator drugs have witnessed a flurry of acquisitions over the past few years, surging in total deal value by more than 780% from $2 billion in 2022 to almost $18 billion in 2024. Credit: JLStock via Shutterstock.

Clinical Trials

Pharmaceutical Technology

JUNE 18, 2025

Can pharma tariffs “Make America Manufacture Again”? June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GATC’s MAT platform identifies potential new drugs and provides comprehensive analytic reports. Credit: Viacheslav Lopatin/Shutterstock. Credit: Viacheslav Lopatin/Shutterstock.

Development

PharmTech

JULY 15, 2025

Related Content Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets Catalent July 16th 2025 Article CDMO Solutions – Reducing Risk and Accelerating Time to Market Experic July 15th 2025 Article Discover how our precision processes and dedicated personal support can expedite even the most complex drug programs.

Development

Pharmaceutical Technology

JUNE 19, 2025

Can pharma tariffs “Make America Manufacture Again”? In a final blow to Eli Lilly’s Kisunla (donanemab) and Eisai’s Leqembi (lecanemab) UK reimbursement prospects, the National Institute for Health and Care Excellence (NICE) has decided against recommending the two Alzheimer’s drugs for NHS use.

Drugs

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? The rapid advancement of AI-powered tools, such as RoseTTAFold and AlphaFold, has revolutionised protein structure prediction, creating exciting opportunities across drug discovery and structural biology.

Protein

Drug Patent Watch

FEBRUARY 19, 2025

The Unsung Heroes of Generic Drugs: The Importance of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the behind-the-scenes efforts that ensure the quality and safety of the medications we rely on. So, what can we learn from the importance of Quality Assurance in generic drugs?

Generic Drugs

Pharmaceutical Technology

JUNE 19, 2025

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Clinical Trials

FDA Law

JUNE 25, 2025

FDA notes that it has, in the past, required single-unit or unit-dose containers for approved new drugs in ODT and film dosage form due to concerns about such products being more palatable than capsules or tablets. The suitable reference product must be a capsule or tablet that is swallowed.

Packaging

Pharmaceutical Technology

JUNE 26, 2025

Can pharma tariffs “Make America Manufacture Again”? A month and a half after winding operations and laying off almost all its staff, Vor Bio has emerged from the brink with a licensing deal potentially rising to $4bn for an autoimmune drug developed by Chinese biotech RemeGen.

Drugs

Pharmaceutical Technology

JUNE 12, 2025

Can pharma tariffs “Make America Manufacture Again”? Novo Nordisk is eyeing a cardiometabolic drug market future that is not purely dominated by incretins, after signing a $812m partnership with Deep Apple Therapeutics to access novel compounds for obesity and other diseases.

Research

Pharmaceutical Technology

JULY 28, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Clinical Trials

XTalks

JULY 10, 2025

Potency assays play a vital role in biopharmaceutical development by measuring a drug candidate’s biological activity against a reference standard — offering essential insights into product quality and its potential clinical success. Dr. Erika Kovacs Sr. In early development, they support candidate selection and help optimize formulations.

Bioassay

Pharmaceutical Technology

JUNE 19, 2025

Can pharma tariffs “Make America Manufacture Again”? Both modalities have emerged as the most used platform technologies in developing oligonucleotide-based drugs for CNS disorders since 2020. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51

Licensing

Pharmaceutical Technology

JUNE 18, 2025

Can pharma tariffs “Make America Manufacture Again”? Donnelly commented: “A big part of our business in genomics is helping pharma companies and biotechs on their drug discovery journey, and part of that is using genetics upstream to help them find better drug targets.

Genomics

Pharmaceutical Technology

JUNE 20, 2025

Can pharma tariffs “Make America Manufacture Again”? June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. Credit: Department of Health Abu Dhabi.

Vaccination

Pharmaceutical Technology

JUNE 25, 2025

Can pharma tariffs “Make America Manufacture Again”? The US Food and Drug Administration (FDA) has expanded the indications of an imaging agent developed by GE HealthCare, which will likely put it at the forefront of the Alzheimer’s diagnostics arena. Credit: Utthapon wiratepsupon via Shutterstock.

Clinical Trials

The Pharma Data

JULY 2, 2025

HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the official launch of WuXiHigh™ 2.0 , a next-generation, high-throughput formulation development platform specifically engineered for high-concentration biologics. WuXi Biologics Launches WuXiHigh™ 2.0 WuXiHigh™ 2.0: Source link

FDA Approval

Scienmag

JUNE 14, 2025

The implications of this technology span from medical diagnostics and targeted drug delivery to environmental monitoring and beyond. Using additive manufacturing techniques combined with microfluidic patterning, they achieved precise sensor placement without introducing mechanical weak points.

Engineer

Pharmaceutical Technology

JUNE 6, 2025

Can pharma tariffs “Make America Manufacture Again”? wants to ensure the ensuing the US does not lag behind other countries in drug development. We are going to make this country the hub of biotechnology innovation,” RFK Jr said during a US Food and Drug Administration (FDA) roundtable on cell and gene therapy on 5 June.

Regulation

Pharmaceutical Technology

JUNE 25, 2025

Can pharma tariffs “Make America Manufacture Again”? GlobalData Healthcare June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Changes to ACIP could result in regulatory uncertainty for vaccine developers and manufacturers. Credit: Melnikov Dimitriy via Shutterstock.

Vaccination

Pharmaceutical Technology

JUNE 23, 2025

Can pharma tariffs “Make America Manufacture Again”? Otsuka will receive exclusive global rights to develop, manufacture and commercialise HBM7020 outside Greater China.

Gene Therapy

PharmTech

JUNE 23, 2025

Among the authorized medicines are six biosimilars and two generic drugs. Text sign showing Industry News. These approvals bring the total medicines approved for authorization in 2025 so far to 56. Austedo (deutetrabenazine) was granted marketing authorization for the treatment of adults with moderate-to-severe tardive dyskinesia.

Manufacturing

Pharmaceutical Technology

JUNE 12, 2025

Can pharma tariffs “Make America Manufacture Again”? Finally, vutrisiran’s launch in the ATTR-CM market will be an opportunity for its manufacturer, Alnylam, to potentially increase sales, as ATTR-wt patient numbers continue growing. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

Clinical Trials

Pharmaceutical Technology

JUNE 18, 2025

Can pharma tariffs “Make America Manufacture Again”? Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for its investigational oral medicine, zagociguat, for mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), a rare mitochondrial disease.

Clinical Trials

PharmTech

JULY 15, 2025

Related Content Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets Catalent July 16th 2025 Article Rethinking Inhalation Drug Development Experic July 15th 2025 Article What it takes to bring complex inhaled therapies to market—faster and smarter.

Marketing

Pharmaceutical Technology

JULY 28, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Marketing

Pharma Marketing Network

JULY 9, 2025

Or would it unravel under the weight of economic retaliation, manufacturing disruptions, and rising drug prices? Table of Contents The Ripple Effects of Tariffs on Drug Pricing Manufacturing Dependencies and Global Disruption Impact on Pharma Marketing and Innovation Budgets Can the Industry Adapt or Will It Fracture?

Manufacturing

Pharmaceutical Technology

JULY 24, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices?

Clinical Trials

Scienmag

JUNE 25, 2025

Spearheaded by researchers at the University of Notre Dame, this comprehensive pharmaceutical evaluation reveals significant discrepancies in the active pharmaceutical ingredient (API) content of chemotherapy drugs sourced from countries including Cameroon, Ethiopia, Kenya, and Malawi.

Drugs

Pharmaceutical Technology

JUNE 10, 2025

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Clinical Trials